This is a Phase III trial of a recombinant interferon to be used for the treatment of patients with chronic HCV infection. The purpose is to compare the effects of the r-metIFN-Con1 with interferon alpha-2b on response in these patients with respect to clearance of HCV viremia from the blood, improvement in liver histology and any differences in the quality of life in the patients.
Showing the most recent 10 out of 871 publications